Clinical Trial Update: A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease

View source ↗

Summary

This ongoing clinical trial in Chinese children and adults with Fabry disease is evaluating enzyme replacement therapy with agalsidase alfa. The study is sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Replagal (agalsidase alfa)

Snippet

Sponsor: Takeda | Conditions: Fabry Disease | Status: RECRUITING